TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Biopharma AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
24,311
|
26,646
|
26,131 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
3,749
|
873
|
3,681 |
Total assets |
11,249
|
16,293
|
15,149 |
Current assets |
11,249
|
16,293
|
15,149 |
Current liabilities |
4,572
|
12,268
|
11,997 |
Equity capital |
5,582
|
2,658
|
1,443 |
- share capital |
30
![]() |
30
![]() |
30 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
49.6%
|
16.3%
|
9.5% |
Turnover per employee | |||
Profit as a percentage of turnover |
15.4%
|
3.3%
|
14.1% |
Return on assets (ROA) |
33.3%
|
5.4%
|
24.3% |
Current ratio |
246.0%
|
132.8%
|
126.3% |
Return on equity (ROE) |
67.2%
|
32.8%
|
255.1% |
Change turnover |
-2,335
|
515
|
-5,318 |
Change turnover % |
-9%
|
2%
|
-17% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.